LyondellBasell Expands Purell Medical-Grade Polymer North American Presence
LyondellBasell, a global major polymer producer and leader in polyolefins technology, has completed the expansion of its Purell product portfolio and further deepened collaboration with customers in the medical sector.

For decades, Purell medical-grade polyolefin material has been the core raw material for European pharmaceutical companies.
This business expansion enables our mature service model, comprehensive compliance system, and extensive product portfolio to be fully implemented in the North American market, thereby better serving local customers.
LYB Healthcare Market Manager Simon Foster stated in a written declaration: "The healthcare industry faces unique developmental pressures and innovation barriers. Since Purell medical-grade polymers expanded into the North American market last year, we have consistently ensured stable supply, enabling our customers to confidently pursue R&D and innovation. Leveraging the Purell service system, we work closely with our customers, providing comprehensive support in regulatory compliance, technology implementation, and stable supply assurance."
Purell series materials are specifically developed for the healthcare sector and are widely used in products such as syringes, ampoules, IV bottles, diagnostic equipment housings, laboratory ware, inhalers, and medical packaging.
Purell's exclusive service system can fully meet customers' stringent quality control and product traceability requirements; complementary exclusive production and logistics management standards are fully compatible with USP, European Pharmacopoeia standards, and drug master file compliance requirements; all production changes will be notified two years in advance, creating industry-leading supply stability.
Natalie Nichols, Senior Director of LYB Special and High-Performance Products, said: "The production of medical devices requires extremely high levels of quality stability, supply reliability, and predictability. With the Purell product portfolio, we can provide dedicated medical-grade polymers for regulatory applications, leveraging dedicated production lines, rigorous quality systems, and global medical customer service experience to build product advantages."
Purell medical-grade polymer has entered the North American market, demonstrating the company's long-term business strategy of focusing on stable production, excellent operations, and in-depth customer collaboration in the compliance terminal field.
【Copyright and Disclaimer】This article is the property of PlastMatch. For business cooperation, media interviews, article reprints, or suggestions, please call the PlastMatch customer service hotline at +86-18030158354 or via email at service@zhuansushijie.com. The information and data provided by PlastMatch are for reference only and do not constitute direct advice for client decision-making. Any decisions made by clients based on such information and data, and all resulting direct or indirect losses and legal consequences, shall be borne by the clients themselves and are unrelated to PlastMatch. Unauthorized reprinting is strictly prohibited.
Most Popular
-
Continental Plans to Begin Sale of ContiTech in Early 2026
-
$4 Billion! Medtronic Makes Another Acquisition
-
BASF Delivers First Batch of Innovative Cathode Materials for Semi-Solid-State Batteries to Weilan New Energy
-
Profit and Revenue Growth Struggle to Conceal Debt Repayment Pressure; Success of Kingfa Sci & Tech's High-End Strategy Yet to Be Seen
-
Why did a century-old european dental instrument giant relocate its manufacturing hub to china?